
Independent Insights, a Health Mart Podcast
Using the KIDs List to Improve Pediatric Medication Safety
Children are at increased risk for medication-related harm because of developmental differences, frequent off-label medication use, and unique adverse effect profiles. The Pediatric Pharmacy Association’s updated KIDs List identifies medications and excipients that should be avoided or used with caution in pediatric patients, providing pharmacists with an evidence-based tool to support safer prescribing and medication use. This course reviews key updates from the 2025 KIDs List and discusses practical strategies pharmacists can use to identify risks, recommend safer alternatives, and improve medication safety for pediatric patients. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact GUEST Rachel Meyers, PharmD, BCPS, BCPPS Clinical Professor / Pediatric Clinical Pharmacist Ernest Mario School of Pharmacy, Rutgers University / Cooperman Barnabas Medical Center Pharmacists, REDEEM YOUR CPE HERE ! CPE is available to Health Mart franchise members only To learn more about Health Mart, click here: https://join.healthmart.com/ PRACTICE RESOURCE Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll ! CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe key medications and excipients included in the 2025 KIDs List and the pediatric safety concerns associated with their use. 2. Identify opportunities for pharmacists to apply KIDs List recommendations when evaluating medication therapy and counseling caregivers of pediatric patients. Rachel Meyers is a Consultant for Wolters Kluwer. All relevant financial relationships have been mitigated. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-316-H01-P Initial release date: 9/7/2026 Expiration date: 9/7/2029 Additional CPE details can be found here .




